Baxter International Inc (BAX)-Product Pipeline Analysis, 2017 Update

Baxter International Inc (BAX)-Product Pipeline Analysis, 2017 Update

  • Products Id :- GDME509PD
  • |
  • Pages: 69
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary

Baxter International Inc (Baxter) is one of the leading providers of renal and hospital products. It undertakes the development, manufacture and marketing of medical products, which assist healthcare professionals and their patients in the treatment of end-stage renal diseases. Its portfolio include a comprehensive range of home, acute and in-center dialysis solutions, sterile IV solutions, infusion systems, parenteral nutrition, biosurgery products and anesthetics, and pharmacy automation, software and services. The products find application in hospitals, kidney dialysis centers, nursing homes, rehabilitation centers and clinics. The company distributes its products through its own direct sales force; independent distributors, drug wholesalers acting as sales agents and specialty pharmacies or other alternate site providers. It has wide spread operations in the Americas, Middle East, Africa, Europe and Asia Pacific. Baxter is headquartered in Deerfield, Illinois, the US.

This report is a source for data, analysis, and actionable intelligence on the company's portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.


The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments

The report analyzes all pipeline products in development for the company Baxter International Inc

The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)

The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date

The report provides detailed description of products in development, technical specification and functions

The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape

Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio

To formulate effective Research & Development strategies

Develop market-entry and market expansion strategies

Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return

Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline

Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

Develop competition strategies by identifying the status and likely launch of the competitors' pipeline products through review of the clinical trials, stage and of development, etc

Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Read More

Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications


Table of Contents

Table of Contents 2

List of Tables 4

List of Figures 5

Baxter International Inc Company Overview 6

Baxter International Inc Company Snapshot 6

Baxter International Inc Pipeline Products and Ongoing Clinical Trials Overview 6

Baxter International Inc-Pipeline Analysis Overview 9

Business Description 9

Baxter International Inc-Key Facts 9

Baxter International Inc-Major Products and Services 10

Baxter International Inc Pipeline Products by Development Stage 13

Baxter International Inc Ongoing Clinical Trials by Trial Status 16

Baxter International Inc Pipeline Products Overview 18

Artis Dialysis System 18

Artis Dialysis System Product Overview 18

Artis Dialysis System Clinical Trial 19

DurADAPT Bioimplant 20

DurADAPT Bioimplant Product Overview 20

ENFit Enteral Syringe 21

ENFit Enteral Syringe Product Overview 21

Hemopatch 22

Hemopatch Product Overview 22

Hemopatch Clinical Trial 23


INDUCTIGRAFT Product Overview 25

Infusion Pump 26

Infusion Pump Product Overview 26

Next-Gen AK98 HD System 27

Next-Gen AK98 HD System Product Overview 27

Next Gen ICHD Monitor 28

Next Gen ICHD Monitor Product Overview 28


Non PVC CAPD Product Overview 29

Non-DEHP Sets 30

Non-DEHP Sets Product Overview 30

Ovart 3D Biodegradable Matrix 31

Ovart 3D Biodegradable Matrix Product Overview 31

Prismaflex Integrated With Gas Exchange Technology 32

Prismaflex Integrated With Gas Exchange Technology Product Overview 32

PrisMAX V1 33

PrisMAX V1 Product Overview 33


PRISMAX V2 Product Overview 34

ProMaxx Microsphere 35

ProMaxx Microsphere Product Overview 35

SepXiris 36

SepXiris Product Overview 36

Sharesource Connect 37

Sharesource Connect Product Overview 37

Synthetic Bone Graft-Orthopaedic 38

Synthetic Bone Graft-Orthopaedic Product Overview 38

Synthetic Bone Graft-Spinal 39

Synthetic Bone Graft-Spinal Product Overview 39

Theralite 40

Theralite Product Overview 40

THERANOVA Dialyser 41

THERANOVA Dialyser Product Overview 41

THERANOVA Dialyser 42

THERANOVA Dialyser Product Overview 42

Tisseel Dura 43

Tisseel Dura Product Overview 43

URINFO 3000 44

URINFO 3000 Product Overview 44

Veritas-Cardiac Application 45

Veritas-Cardiac Application Product Overview 45

VIVIA Hemodialysis System 46

VIVIA Hemodialysis System Product Overview 46

VIVIA Hemodialysis System Clinical Trial 47

Baxter International Inc-Key Competitors 48

Baxter International Inc-Key Employees 49

Baxter International Inc-Key Employee Biographies 50

Baxter International Inc-Locations And Subsidiaries 51

Head Office 51

Other Locations & Subsidiaries 51

Affiliate 57

Joint Venture 57

Recent Developments 58

Baxter International Inc, Recent Developments 58

Apr 03, 2017: Baxter Unveils Design Enhancement to TISSEEL Hemostatic Agent at AORN Meeting 58

Apr 03, 2017: Baxter Unveils Design Enhancement to FLOSEAL Hemostatic Agent at AORN Meeting 58

Mar 14, 2017: New Data Indicates Use of Baxter's FLOSEAL in Cardiac and Spinal Surgeries May Be Associated with Lower Hospital Costs 59

Feb 16, 2017: Baxter Debuts Enteral Nutrition ENFit Syringe and Accesory Line During Clinical Nutrition Week 2017 59

Feb 08, 2017: Baxter Appoints Dr. Stephen Oesterle to Its Board 60

Feb 01, 2017: Baxter Reports 2016 Fourth-Quarter and Full-Year Results 61

Dec 05, 2016: Baxter Introduces New Safety Management System and Software Updates for Sigma Spectrum Infusion System at ASHP Meeting 62

Nov 22, 2016: Baxter Presented Exploratory Research on the Removal of Inflammation-Related Molecules During Extracorporeal Blood Purification Therapy 63

Nov 21, 2016: New Data Presented at ASN Kidney Week Spotlight Baxter's SHARESOURCE Telehealth Platform and AMIA APD System in Supporting More Efficient Home Dialysis Care 64

Nov 17, 2016: Baxter to Present 24 Abstracts at ASN Kidney Week 2016 Focused on Elevating the Standard of Care For Dialysis Patients Globally 64

Appendix 66

Methodology 66

About GlobalData 68

Contact Us 68

Disclaimer 68

List of Figures

Baxter International Inc Pipeline Products by Equipment Type 7

Baxter International Inc Pipeline Products by Development Stage 13

Baxter International Inc Ongoing Clinical Trials by Trial Status 16

List of Tables

Baxter International Inc Pipeline Products and Ongoing Clinical Trials Overview 6

Baxter International Inc Pipeline Products by Equipment Type 7

Baxter International Inc Pipeline Products by Indication 8

Baxter International Inc Ongoing Clinical Trials by Trial Status 8

Baxter International Inc, Key Facts 9

Baxter International Inc, Major Products and Services 10

Baxter International Inc Number of Pipeline Products by Development Stage 13

Baxter International Inc Pipeline Products Summary by Development Stage 14

Baxter International Inc Ongoing Clinical Trials by Trial Status 16

Baxter International Inc Ongoing Clinical Trials Summary 17

Artis Dialysis System-Product Status 18

Artis Dialysis System-Product Description 18

Artis Dialysis System-Automated Setting of Individualized Sodium Technology (ASIST)-Proof of Principle Study 19

DurADAPT Bioimplant-Product Status 20

DurADAPT Bioimplant-Product Description 20

ENFit Enteral Syringe-Product Status 21

ENFit Enteral Syringe-Product Description 21

Hemopatch-Product Status 22

Hemopatch-Product Description 22

Hemopatch-A Phase II Prospective, Single Blinded, Randomized Trial of Hemopatch Compared to Standard Techniques to Achieve Air Leak Control After Complex Thoracic Surgical Procedures on High Risk Population for Prolonged Air Leak (more than 5 Days-PAL) 23

Hemopatch-A Prospective Randomized Trial of Hemopatch Versus No Hemopatch for the Intraoperative Hemostasis During Deceased Donor Renal Transplant 23

Hemopatch-Phase III, Randomized, Unblinded, Controlled Clinical Trial for Evaluating the Effectiveness of the use of the New Hemostatic Patch Hemopatch in Patients undergoing Surgical Liver Resection 23

Hemopatch-Prospective Randomized Clinical Trial to Prevent Air Leaks After Lung Resection with Hemopatch Sealing Hemostat: SEALLS (Sealing Evaluation of Air Leaks After Lung Surgery) Trial 24

Hemopatch-Prospective, Multicenter, Open-label, Randomized, Phase III Clinical Trial of Prevention of Prolonged Air Leak after Lung Resection in High-risk Patients, Applying HEMOPATCH 24

INDUCTIGRAFT-Product Status 25

INDUCTIGRAFT-Product Description 25

Infusion Pump-Product Status 26

Infusion Pump-Product Description 26

Next-Gen AK98 HD System-Product Status 27

Next-Gen AK98 HD System-Product Description 27

Next Gen ICHD Monitor-Product Status 28

Next Gen ICHD Monitor-Product Description 28

Non PVC CAPD-Product Status 29

Non PVC CAPD-Product Description 29

Non-DEHP Sets-Product Status 30

Non-DEHP Sets-Product Description 30

Ovart 3D Biodegradable Matrix-Product Status 31

Ovart 3D Biodegradable Matrix-Product Description 31

Prismaflex Integrated With Gas Exchange Technology-Product Status 32

Prismaflex Integrated With Gas Exchange Technology-Product Description 32

PrisMAX V1-Product Status 33

PrisMAX V1-Product Description 33

PRISMAX V2-Product Status 34

PRISMAX V2-Product Description 34

ProMaxx Microsphere-Product Status 35

ProMaxx Microsphere-Product Description 35

SepXiris-Product Status 36

SepXiris-Product Description 36

Sharesource Connect-Product Status 37

Sharesource Connect-Product Description 37

Synthetic Bone Graft-Orthopaedic-Product Status 38

Synthetic Bone Graft-Orthopaedic-Product Description 38

Synthetic Bone Graft-Spinal-Product Status 39

Synthetic Bone Graft-Spinal-Product Description 39

Theralite-Product Status 40

Theralite-Product Description 40

THERANOVA Dialyser-Product Status 41

THERANOVA Dialyser-Product Description 41

THERANOVA Dialyser-Product Status 42

THERANOVA Dialyser-Product Description 42

Tisseel Dura-Product Status 43

Tisseel Dura-Product Description 43

URINFO 3000-Product Status 44

URINFO 3000-Product Description 44

Veritas-Cardiac Application-Product Status 45

Veritas-Cardiac Application-Product Description 45

VIVIA Hemodialysis System-Product Status 46

VIVIA Hemodialysis System-Product Description 46

VIVIA Hemodialysis System-A Study of Sleep Patterns in Patients Performing Nocturnal Home Dialysis Utilizing the VIVIA System 47

VIVIA Hemodialysis System-U.S. Clinical Trial for VIVIA Investigational Home Hemodialysis System 47

Baxter International Inc, Key Employees 49

Baxter International Inc, Key Employee Biographies 50

Baxter International Inc, Other Locations 51

Baxter International Inc, Subsidiaries 51

Baxter International Inc, Affiliate 57

Baxter International Inc, Joint Venture 57

Glossary 67

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to sales [@]

NxStage Medical Inc, Johnson & Johnson, Hospira Inc, Fresenius Medical Care AG & Co KGaA, Bristol-Myers Squibb Company, Boston Scientific Corp, Becton Dickinson and Co, Abbott Laboratories

select a license
Single User License
USD 750 INR 53430
Site License
USD 1500 INR 106860
Corporate User License
USD 2250 INR 160290



The report was very informative and gives me an interesting view on the Indian market....

We would like to thank the entire team of Ken Research in showcasing professionalism in research and quick turnaround time. We have had multiple research reports from Ken Research. The deadline communicated for research was duly met. The research reports were covering many aspects in detail. This showcases their endeavor and care for client satisfaction and a strong understanding of the clients’ requirements. Thank you again for your help...

I appreciate their diligence and determination in customizing the research project. The data proves to be valuable and accurate. I would, in future, definitely use their services again...

I would like to thank Ken research team for meeting our report deliverables. The report is very good and we appreciate your well cooperation. ...

The research you conducted was very helpful for us and the integrity of your research approach gave us great confidence in the data. Look forward to collaborating again in future...

Ken Research Private Limited, Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India


Company Brochure

Engage with Us

sales [@]